These two polysaccharides regulated metabolic disorders through inhibiting insulin and glucose tolerance, serum insulin and glucose levels, reducing serum and hepatic lipid profiles, liver function enzymes and pro-inflammatory cytokines, suppressing hepatic oxidative stress and hepatic lipid accumulation. The gene discussed is INS; the disease is metabolic disease.